(702) 683-8946

Monday - Friday 9am to 5pm



Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)



CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business


Latest News Releases From The Newsroom

FTC Sues Amazon for Illegally Maintaining Monopoly Power

September 27th, 2023

Amazon’s ongoing pattern of illegal conduct blocks competition, allowing it to wield monopoly power to inflate prices, degrade quality, and stifle innovation for consumers and businesses Washington D.C. / CRWE PRESS RELEASE / September 26, 2. Read more

Bullish View On Blink Charging; Pfizer Deal Boosts Ginkgo Bioworks

September 27th, 2023

UBS has initiated coverage on Blink Charging Co. (Nasdaq: BLNK), a leading provider of electric vehicle charging services, with a Buy rating and a price target of $7. With $BLNK closing at $2.93 on Tuesday, the price target suggests a significant . Read more

Galecto Seeks Strategic Options; Palantir Lands $250M Army Contract

September 26th, 2023

Shares of Galecto, Inc. (Nasdaq: GLTO) surged by more than 30% in after-hous trading following the company's announcement of a comprehensive review of its business operations. Galecto aims to explore strategic alternatives focused on maximizing sh. Read more

MillerKnoll Beats Wall Street Forecasts; Rocket Lab Lowers Outlook

September 26th, 2023

MillerKnoll, Inc. (Nasdaq: MLKN) reported robust first-quarter fiscal 2024 earnings, coming in at $0.37 per share, surpassing the consensus EPS estimate of $0.21. The company also exceeded revenue expectations, with quarterly sales reaching $917.70 m. Read more

PWS Study Data Boost Soleno Therapeutics; Bullish View on Fisker

September 26th, 2023

Shares of Soleno Therapeutics, Inc. (Nasdaq: SLNO) soared over 300% in pre-market trading following the release of positive top-line results from Study C602.  The study, which focused on the long-term treatment of Prader-Willi syndrome (PWS) . Read more

Immunovant's IMVT-1402 Data Sparks Momentum; Ferguson Outperforms Estimates

September 26th, 2023

Shares of Immunovant, Inc. (Nasdaq: IMVT) surged by more than 40% in pre-market trading after promising Phase 1 trial results for IMVT-1402. Administered subcutaneously in healthy adults, IMVT-1402 demonstrated significant dose-dependent reductions i. Read more

Breaking: FDA Greenlights Profound Medical's TULSA AI Module

September 26th, 2023

Shares of Profound Medical Corp. (Nasdaq: PROF) surged by more than 10% in after-hours trading after it announced FDA clearance for its Thermal Boost module in conjunction with TULSA-PRO, which allows surgeons to treat various prostate conditions, in. Read more

FDA Clearance Sparks Femasys Surge; THOR Industries Tops Estimates

September 25th, 2023

Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment. Read more

Crown Equity Holdings, Inc. Files Registration Statement on Form S-1 for Proposed Public Offering of its Common Stock

September 25th, 2023

LAS VEGAS, NV / CRWE PRESS RELEASE / September 25, 2023  -  Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a pro. Read more

Breaking: European Commission Rebuffs Booking's eTraveli Deal

September 25th, 2023

The European Commission has put a halt to Booking Holdings Inc.'s (Nasdaq: BKNG) proposed acquisition of Flugo Group Holdings AB (eTraveli) under the EU Merger Regulation. This decision comes after an in-depth investigation, which revealed that th. Read more